Plantar Fasciitis in Athletes: Prevention & Recovery

Key Takeaways

• Plantar fasciitis in athletes is primarily a clinical diagnosis. Medial plantar heel pain, especially with the first steps after rest, is a typical pattern, but heel pain alone is not enough to establish the diagnosis.
• In my clinical experience, the condition is common in people with a high cumulative load on the feet, including those who spend long periods standing at work and people who do repetitive weight-bearing exercise such as running.
• Flat-foot posture did not emerge as a clear risk factor in the literature reviewed for this article. This was a useful reminder to me that a clinical impression is not the same thing as an established risk factor.
• Imaging is usually not needed in a straightforward case. MRI or ultrasound can become relevant when the diagnosis is uncertain or another cause of heel pain is being considered.
• Plantar fascia-specific stretching remains guideline-supported. Recent larger trials did not show a clear additional benefit from structured strengthening on top of basic care, and the plantar fascia should not automatically be treated as if it were simply another tendon.
• Taping and night splints can be useful short-term tools, particularly when first-step pain is prominent, but they are best viewed as part of a broader management plan rather than stand-alone solutions.
• Corticosteroid injection may provide short-term symptom relief, but the benefit does not appear to persist clearly at later follow-up. Plantar fascia rupture has been reported, and its true incidence remains uncertain.
• In practice, I prefer active management over rest alone. Load modification, stretching, and physiotherapy when needed are often more useful than simply telling the patient to stop activity and wait.
• Recovery can take months, and a substantial minority of patients still report symptoms years later. Evidence specifically addressing plantar fasciitis in competitive athletes remains limited, so some treatment decisions still depend on careful clinical judgment.

Introduction: Plantar Fasciitis in Athletes

Plantar fasciitis is the injury that turns the first steps out of bed into a negotiation. In my own clinical work, I come across it regularly, and not only in athletes. I often see it in people whose work keeps them on their feet for long periods, including healthcare workers such as nurses. When I assess these patients, there is rarely just one obvious explanation. I may see a combination of high cumulative loading, footwear that is poorly suited to the person or the demands of the job, and differences in foot posture or biomechanics. I do not take any one of these findings as proof of causation, but in practice they can help me understand the overall loading pattern around the symptoms.

For athletes, the condition can be especially frustrating because onset is usually related to a change in weight-bearing activity.[1] The 2023 clinical practice guideline from the Academy of Orthopaedic Physical Therapy describes plantar fasciitis as medial plantar heel pain with tenderness at the medial calcaneal tubercle, most noticeable with weight-bearing first thing in the morning or after a period of rest.[1] It typically begins gradually and is usually related to a change in weight-bearing activity.[1]

From my perspective, plantar fasciitis is usually more useful to think about as a loading problem with several possible contributing factors rather than as a condition with one single mechanical cause. This article covers how common it is in athletes, what may be happening in the fascia, who appears to be at greater risk, how the diagnosis is made and what else can mimic it, which recovery strategies have evidence, how long recovery can take, and what is—and is not—known about prevention. Where the evidence is thin, I say so, and for treatment in athletes it often is.

How Common Is Plantar Fasciitis in Athletes?

The guideline reports that it contributes to approximately 15% of foot pathology in the general population, occurs most commonly between the ages of 40 and 60 without a sex bias, and has a reportedly higher incidence in runners.[1] Occupations that involve a lot of standing may also be more affected.[1]

For a sense of scale in runners, a Vancouver sports medicine centre recorded running injuries over two years and reported that patellofemoral pain syndrome was the most common injury, followed by iliotibial band friction syndrome, plantar fasciitis, meniscal injuries of the knee, and tibial stress syndrome.[2] This is a clinic-based sample of injured runners (54% women), so it tells you where the condition ranks among runners who sought care, not how often it occurs among all runners.[2]

Athlete-specific evidence on treatment is limited. A scoping review of plantar fasciopathy in elite athletes identified 10 eligible studies covering 109 athletes.[3] Only 18 of those athletes took part in a therapeutic investigation, the largest treatment cohort included just 6 elite athletes, and the highest score any study reached on the modified Coleman Methodology Score was 42 out of 100 (below 50 is classed as poor).[3] The authors concluded that until higher-quality studies exist, clinicians have to rely on the literature from non-professional and non-athletic populations.[3] That is the literature summarized below, so read the treatment sections with that caveat in mind.

In my clinical work, when a patient comes in with pain under the foot or around the heel, plantar fasciitis is often high on the list of possibilities. The location matters. Pain centred more distally around the forefoot is a different clinical problem, but when the tenderness is on the plantar aspect of the heel, particularly toward the medial side, the overall symptom pattern often fits plantar fasciitis.

That does not mean that every case of plantar heel pain is plantar fasciitis. In practice, I still look at the exact location of the pain and the broader clinical picture before settling on the diagnosis. But medial plantar heel pain is one of the patterns that makes plantar fasciitis clinically plausible very early in the assessment.

Is Plantar Fasciitis Really Inflammation?

Despite the name, the guideline notes that it is widely understood to exist along a spectrum that includes both inflammatory and degenerative characteristics.[1] In one histologic series of 50 heel spur surgeries for chronic plantar fasciitis, the authors found myxoid degeneration with fragmentation and degeneration of the plantar fascia, plus bone marrow vascular ectasia, and argued the condition is a degenerative fasciosis rather than a fasciitis.[11] Surgical specimens come from people who had surgery for the chronic condition, so they do not necessarily represent the early stage in a runner whose pain started three weeks ago.

Imaging findings can persist after symptoms settle. In a cohort of ultrasound-diagnosed patients followed for a mean of 9.7 years, fascia thickness decreased in both symptomatic and asymptomatic patients, but only 24% of the asymptomatic group had a plantar fascia with a normal ultrasound appearance.[9] Baseline fascia thickness did not predict long-term prognosis.[9] In the high-load training trial discussed below, most patients still had a thickened fascia after treatment even though symptoms had improved.[8] The practical implication is that fascia thickness on ultrasound is an imperfect marker of recovery.

In my view, plantar fasciitis often behaves more like a tendinopathy-type problem than a straightforward inflammatory condition. Clinically, the pattern can feel closer to a load-related soft-tissue disorder than to an acute inflammatory process. That is also why I am cautious about interpreting the name fasciitis too literally: in many patients, the condition is not simply an inflammation of the plantar fascia per se.

This fits reasonably well with the broader pathological picture described in the literature, where degenerative changes have been reported alongside inflammatory features. I therefore find it more useful to think of plantar fasciitis as a condition that can sit somewhere on that spectrum rather than as a purely inflammatory disorder.

Risk Factors in Active People

The guideline’s risk-factor recommendation (grade B) asks clinicians to assess limited ankle dorsiflexion range of motion, high body mass index in nonathletic individuals, running, and work-related weight-bearing activity, particularly under conditions with poor shock absorption.[1]

For athletes specifically, a systematic review and meta-analysis compared physically active people with and without the condition. It included 16 studies and pooled 11 risk factors.[4] Increased plantarflexion range of motion (weighted mean difference 7.04°; 95% CI 5.88–8.19), higher body mass index (2.13 kg/m²; 95% CI 1.40–2.86), and higher body mass (4.52 kg; 95% CI 0.55–8.49) were identified as risk factors. The authors rated the evidence level 3 because of inconsistent definitions and blinding in the observational studies.[4]

Two cautions apply. First, the included studies were observational comparisons of active people with and without the condition,[4] so in my reading they cannot show that a factor came first. Second, the guideline’s dorsiflexion limitation and the meta-analysis’s plantarflexion finding are different measurements, so one does not simply confirm or contradict the other.

One finding that genuinely surprised me when reviewing the literature was that flat-foot posture did not emerge as a clear risk factor. Clinically, I had intuitively linked plantar fasciitis with pes planus because I often notice a flatter foot posture in patients with heel pain. But on reflection, that may simply be an example of overinterpreting what I see in practice: flat feet are common in the general patient population as well, so seeing the two together does not necessarily mean that one is driving the other.

For me, this is a useful reminder of the difference between a clinical impression and an established risk factor. A pattern can feel convincing at the bedside and still fail to hold up when it is tested systematically.

How the Diagnosis Is Made (and What Else Can Feel Like It)

The guideline’s diagnostic picture combines history and examination: plantar medial heel pain that is most noticeable with the first steps after inactivity but also worse after prolonged weight-bearing; onset after a recent increase in weight-bearing activity; pain on palpation of the proximal insertion of the plantar fascia; a positive windlass test; negative tarsal tunnel tests; limited ankle dorsiflexion; and an abnormal Foot Posture Index-6 score.[1]

In my clinical experience, pain under the heel—especially toward the medial side—is a very typical pattern in plantar fasciitis, although it is not specific enough to make the diagnosis on its own. This is also where the guideline’s diagnostic description fits well with what I tend to see in practice: plantar medial heel pain, tenderness around the proximal plantar fascia, and symptoms that are particularly noticeable with the first steps after inactivity.[1]

I seem to encounter this pattern particularly in people who spend much of the working day on their feet. Healthcare workers, including nurses, are one group in which I come across it regularly in clinical practice. I also see the same kind of heel pain in people who do a lot of repetitive weight-bearing exercise, such as running. In those situations, I think of the location of the pain together with the overall loading history rather than assuming that heel pain alone is enough to establish the diagnosis.

Imaging is usually not indicated when a patient meets these clinical criteria until they fail conservative treatment. If imaging is considered, weight-bearing radiography comes first. If radiographs are negative and the diagnosis is still suspected, MRI or diagnostic ultrasound is usually the next step.[1] Ultrasound findings suggested as diagnostic include fascial thickening exceeding 4 mm and a hypoechoic appearance, but the guideline notes that some imaging findings are nonspecific and can also be seen in people without symptoms.[1]

In clinical practice, I occasionally see a very characteristic calcaneal spur on a patient’s radiograph. My impression is that this tends to come up more in longer-standing cases, although the spur itself does not tell you how long the patient has been symptomatic. It may also represent a structural change that developed during a period when the condition was not causing noticeable symptoms. For that reason, I treat the radiographic finding as part of the overall picture rather than as a direct measure of current symptom severity.

Not every heel pain is plantar fasciitis. The guideline calls plantar heel pain an umbrella term and lists heel fat pad syndrome, heel spur syndrome, nerve irritation, and calcaneal stress fracture among the other causes.[1] It recommends assessing for other diagnoses, including spondyloarthritis, fat-pad atrophy, and proximal plantar fibroma, when symptoms do not fit the expected pattern or are not resolving with treatment aimed at the person’s impairments.[1] In a retrospective review of 250 patients at a Korean foot clinic (patients with systemic inflammatory or rheumatic disease were excluded), plantar fasciitis accounted for 53.2% of plantar heel pain, fat pad atrophy for 14.8%, pes cavus for 10.4%, and plantar fasciitis with fat pad atrophy for 9.2%.[12] First-step morning pain and tenderness at the medial calcaneal tuberosity correlated with plantar fasciitis, whereas fat pad atrophy mainly involved bilateral pain, night pain, and pain aggravated by standing.[12]

Two mimics deserve special attention in athletes:

• Calcaneal stress fracture. Patients often report onset after an increase in weight-bearing activity or a change to a harder walking surface. The pain starts only with activity but often progresses to pain at rest, and point tenderness at the fracture site is usually indicative. Radiography often does not show the fracture initially, so bone scan or MRI may be needed.[13]
• Nerve entrapment. Burning, tingling, or numbness suggests a neuropathic cause. Neuropathic heel pain is usually unilateral, so underlying systemic illness should be ruled out in people with bilateral pain.[13]

What about blood tests? The guideline’s diagnostic criteria are built from history, palpation, and clinical tests, and they contain no laboratory test.[1] Spondyloarthritis appears in both the guideline’s differential and a family-medicine review’s list of arthritic causes of heel pain.[1][13] Neither source provides a laboratory-testing algorithm, so if such a cause is suspected, which tests to order, and when, is a matter of clinical judgment rather than a tested rule.

In most cases, I consider plantar fasciitis a clinical diagnosis. The history and examination are usually enough to make the picture reasonably clear, and imaging is not routinely needed. In more ambiguous cases, MRI can sometimes become relevant, particularly if the symptoms do not fit the usual pattern or another diagnosis is being considered.

In my own work, MRI is used relatively rarely for straightforward plantar fasciitis in the public healthcare setting. I tend to see it used more often in occupational healthcare or insurance-funded pathways, where access to advanced imaging may be easier. Even then, I see MRI mainly as a tool for clarifying an uncertain diagnosis rather than something that is required to confirm a typical case.

Plantar Fasciitis Recovery: What the Evidence Supports

The 2023 guideline focuses on interventions within physical therapist practice, and its literature search ran to March 2023.[1] Shockwave therapy, corticosteroid injection, and platelet-rich plasma (PRP) were covered in a scoping summary because they are frequently prescribed and may be worth considering in patients who are not benefiting from physical therapy.[1] Two large randomized trials were published after that search and bear directly on exercise and shockwave, so I present the guideline first and the newer trials after it.

Approach	2023 guideline stance	Key detail
Plantar fascia-specific and gastrocnemius/soleus stretching	Grade A: use	For short- and long-term pain and function; plantar fascia stretching judged an essential component
Resistance training for foot and ankle	Grade B: use	Insufficient evidence to identify a superior type of strength training or exercise
Foot taping (rigid or elastic)	Grade A: use alongside other treatment	Short-term (1 to 6 weeks) gains in pain and function
Night splint	Grade A: 1- to 3-month program if consistent first-step pain	No new studies in 2023 update; carried over from 2014
Foot orthoses	Grade B: not as an isolated treatment for short-term pain relief; grade C: may use combined with other treatments	Small to no stand-alone effect in meta-analyses

Source for all rows: the 2023 guideline.[1] The guideline also supports manual therapy (grade A), dry needling of myofascial trigger points in the calf and foot muscles (grade B), and low-level laser therapy for short-term pain reduction (grade B), and it advises against adding therapeutic ultrasound to stretching (grade A).[1]

Stretching

The guideline judged plantar fascia stretching an essential component of stretching therapy. It based this on a meta-analysis of 8 randomized trials (n = 681) in which moderate-quality evidence showed plantar fascia stretching was superior to gastrocnemius/soleus stretching in the short term (under 3 months); evidence beyond 3 months was limited.[1] In Rathleff’s trial the plantar-specific stretch was done seated with the affected leg crossed over the other. The fingers go across the base of the toes and pull them toward the shin until a stretch is felt in the arch, while the other hand palpates the fascia to confirm tension. Patients performed 10 repetitions of 10 seconds, three times per day.[8]

In practice, I usually give patients an active home program rather than relying on a passive treatment alone. Stretching is often part of that plan, and in some cases I also use a night splint, particularly when first-step pain in the morning is a prominent symptom. I see these measures as practical tools that can be combined with the broader management plan rather than as stand-alone solutions.

Strength training: a good rationale, mixed trial results

Rathleff and colleagues randomized 48 patients with ultrasound-verified plantar fasciitis to plantar-specific stretching or high-load strength training. Both groups also received gel heel inserts and an information sheet covering pain management, activity modification, and a gradual return to sport.[8] The strength protocol was unilateral heel raises with a towel under the toes to increase toe dorsiflexion, performed every second day: 3 seconds up, a 2-second pause at the top, and 3 seconds down. It started at 12 repetition maximum for 3 sets, moved to 10RM for 4 sets after 2 weeks and to 8RM for 5 sets after 4 weeks, with load added using a backpack of books.[8] At the primary 3-month endpoint the strength group’s Foot Function Index was 29 points lower than the stretch group’s (95% CI 6–52; P = 0.016; effect size 0.81). At 1, 6, and 12 months the differences were not significant (P > 0.34). Adherence was not recorded, and fascia thickness did not fall more with strengthening than with stretching.[8] A second high-quality trial summarized in the guideline compared strengthening with stretching in 84 patients and found no significant differences between groups.[1]

Two later trials asked a different question: does adding exercise to good advice help?

• Riel 2023 (180 adults with ultrasound-confirmed plantar fasciopathy). Participants were randomized to patient advice plus a heel cup, the same plus self-dosed heavy–slow heel-raise resistance training, or the same plus that training and an ultrasound-guided triamcinolone injection; the primary outcome was the Foot Health Status Questionnaire pain domain at 12 weeks, with a minimal important difference of 14.1 points. There was no statistically significant difference between advice plus heel cup and the exercise arm at any time point, and none between the exercise arm and the exercise-plus-injection arm.[5]
• Heide 2024 (200 patients with heel pain for more than 3 months). Everyone received advice and custom foot orthoses, then was randomized to radial shockwave, sham shockwave, an exercise program, or nothing further. The exercise program was unilateral heel raises and leg squats three times a week for 12 weeks, including eight supervised sessions, progressing from 12RM toward 6RM. At 6 months, pain during activity (0–10 scale) did not differ significantly from the advice-plus-orthoses group for shockwave (−0.02; 95% CI −1.01 to 0.96), sham shockwave (0.52; 95% CI −0.49 to 1.53), or exercise (−0.11; 95% CI −1.11 to 0.89).[6] Everyone improved: in the advice-plus-orthoses group, pain during activity fell from 6.30 to 3.71.[6]

A 2026 systematic review of randomized trials comparing exercise with no exercise found only three eligible studies (146 participants, moderate-to-high risk of bias), two of which tested stretching only. Exercise was favored over no intervention for pain (standardized mean difference −1.10; 95% CI −2.01 to −0.19), but certainty was low and the authors described the benefit as of uncertain relevance, especially for programs of 3 months or less.[7]

How to reconcile these findings? Rathleff’s trial compared heel-raise exercise with stretching, while the newer trials compared structured exercise added to basic care with basic care alone.[8][5][6] Heel-raise loading may speed early progress relative to stretching, but on top of good advice and a heel cup or orthosis, the added exercise produced no statistically significant additional pain reduction in the larger trials.[5][6]

One point I find particularly useful here is that the plantar fascia is not a tendon and has no direct in-line muscular attachment. The Heide authors raised this as one possible reason why the tissue may respond differently to high-load strength training than other lower-limb tendons.[6] Clinically, that makes me cautious about treating plantar fasciitis as if it were simply another Achilles or patellar tendinopathy. I would not take the current evidence to mean that eccentric or resistance exercise does not work, but I do think it argues against assuming that the same rehabilitation logic transfers directly from tendon disorders to the plantar fascia. Plantar fascia-specific stretching remains guideline-supported, while the more recent trials have not shown a clear additional benefit from structured strengthening on top of basic care.

The Heide trial also had important limitations. Few patients reached the heaviest load of 6RM at weeks 9–12, only 74% of the exercise group completed the programme per protocol, and most participants had long-standing symptoms in a specialist hospital setting while all received custom orthoses.[6] Only 9 of the 196 participants who answered the activity-level question reported exercise or competition as their activity level, so its results cannot be assumed to apply to competitive athletes.[6]

Taping, night splints, and orthoses

Foot taping earned a grade A recommendation as an add-on to other treatment for short-term improvements in pain and function. A meta-analysis summarized in the guideline found low-dye taping reduced pain compared with controls at 1 to 6 weeks (4 studies, n = 231; mean difference −3.60, 95% CI −4.16 to −3.03).[1] Night splints, worn during sleep to prevent ankle plantar flexion, are recommended as a 1- to 3-month program for people who consistently have first-step pain, although the 2023 update found no new studies and carried the recommendation over from 2014.[1]

Night splints hold the ankle in dorsiflexion during sleep, which also maintains tension through the plantar fascia and calf–Achilles complex. Whether their clinical effect comes from stretching the plantar fascia itself, maintaining ankle dorsiflexion overnight, or a combination of these mechanisms is not well established.

Orthoses are more nuanced. The guideline advises against using them as an isolated treatment for short-term pain relief but allows them in combination with other treatments. Its reasoning: four meta-analyses suggested a small to no stand-alone effect over less than 3 months, and custom and prefabricated orthoses did not differ significantly.[1] Because every participant in the Heide trial received custom orthoses, that trial cannot tell us how much the orthoses themselves contributed to the improvement.[6]

Shockwave and corticosteroid injections

A 2017 meta-analysis of nine studies (935 patients) found that extracorporeal shockwave therapy (ESWT) had higher improvement rates than placebo in chronic cases (odds ratio 2.58; 95% CI 1.97–3.39). Focused shockwave produced greater pain-relief success than placebo (OR 2.17; 95% CI 1.49–3.16). However, the authors said no firm conclusions could be drawn for radial or general ESWT, and heterogeneity was high.[14] A 2021 best-practice guide that combined a systematic review with expert opinion proposed core treatment of taping, stretching, and individualized education, with shockwave offered to people who do not improve optimally.[15] The later sham-controlled trial of radial shockwave described above found no additional benefit over advice plus orthoses. Blinding was imperfect (61% of patients in the sham group believed they had received real treatment), which the authors flagged as a source of uncertainty.[6] My summary is that the shockwave evidence is mixed.[14][15][6]

Corticosteroid injection trades short-term relief against a reported risk of plantar fascia rupture, although its incidence is uncertain.[16][17] In a randomized, placebo-controlled trial of 82 people, ultrasound-guided dexamethasone reduced pain more than saline at 4 weeks (10.9 points on the Foot Health Status Questionnaire; 95% CI 1.4–20.4; P = 0.03). Differences in pain at 8 and 12 weeks were not statistically significant, and the authors noted that even the 4-week difference only approached the 13-point minimal important difference. No adverse events were reported, including plantar fascia rupture, but this was a single dexamethasone injection in 82 people, too few to rule out uncommon complications.[16] In Riel’s trial the exercise-plus-injection arm (ultrasound-guided triamcinolone) was statistically better than advice plus heel cup alone at 12 weeks (adjusted mean difference −9.1; 95% CI −16.8 to −1.3, favouring the injection arm), but the difference never exceeded the minimal important difference at any follow-up.[5]

Rupture is the concern. In a case series of 765 patients with the condition, evaluated by one of the authors, 51 were diagnosed with plantar fascia rupture and 44 of those ruptures were associated with corticosteroid injection. In most cases rupture relieved the original heel pain, but these patients subsequently developed new problems including longitudinal arch strain and stress fracture, and 26 feet were still symptomatic one year after rupture.[17] Because that was a single-author case series, it shows that rupture can occur but cannot give a reliable incidence (the authors had themselves injected 122 of the 765 patients, and 12 of the 44 injection-associated ruptures followed those injections).[17] In the long-term cohort mentioned earlier, fat pad thickness did not differ between patients who had received ultrasound-guided corticosteroid injections (9.0 mm) and those who had not (9.4 mm; P = .66).[9]

In practice, patients occasionally ask specifically about a corticosteroid injection, especially when the heel pain has been persistent and other measures have not given enough relief. My clinical impression is that an injection can sometimes reduce symptoms quite noticeably, but I do not frame it as a long-term solution. The randomized trials support that distinction: the benefit appears to be mainly short term, and the average improvement does not clearly persist at later follow-up.[16][5]

This usually leads to a discussion about the trade-off between temporary pain relief and the reported risk of plantar fascia rupture. I would be particularly cautious about dismissing that risk in an athlete, because rupture can interfere substantially with training and return to sport, and cases have been reported in athletes after corticosteroid injection.[17] I would not, however, assume that the rupture risk is unimportant in a non-athlete; the available evidence does not support making that distinction. For me, the more relevant point is that corticosteroid injection may offer short-term symptom relief, while the potential complication is uncommon but potentially consequential and the true incidence remains uncertain.

How Long Does Plantar Fasciitis Take to Recover?

Two bodies of evidence point in different directions, and both matter.

Long-term follow-up. Hansen and colleagues diagnosed 269 patients with the condition by symptoms and ultrasound between 2001 and 2011, and 174 of them took part in a follow-up in 2016, a mean of 9.7 years after symptom onset. At follow-up 54% were asymptomatic (with a mean symptom duration of 725 days) and 46% still had symptoms. Using Kaplan-Meier estimates, the risk of having the condition was 80.5% at 1 year, 50.0% at 5 years, 45.6% at 10 years, and 44.0% at 15 years after symptom onset. Prognosis was significantly worse for women and for patients with bilateral pain, whereas baseline fascia thickness and the presence of a heel spur had no impact.[9] The study was observational, so it cannot tell us which treatments worked.[9]

Trial follow-up. In the Oslo trial, pain during activity improved significantly in all four groups by 6 months, and on a global impression-of-change scale that asks about general health status, 12.5% of patients at 6 months reported being “very much improved,” 30.5% “much improved,” 31% “minimally improved,” and 19.5% “unchanged.”[6] A secondary analysis reported gradual improvement in pain, function, and quality of life over 12 months, with the largest improvement in the first 3 months, but bilateral pain was associated with a lack of improvement between 6 and 12 months.[18]

In the Oslo trial about three quarters of patients reported at least minimal improvement in general health status at 6 months,[6] the secondary analysis found the largest gains in the first 3 months,[18] and in the Hansen cohort 46% still had symptoms at a mean of 9.7 years.[9] Bilateral pain was linked with worse outcomes in both, although the outcomes and study designs differed.[9][18] Neither cohort was specific to athletes, so I would not assume they describe a competitive athlete’s timeline. Set expectations in months, not days. Rathleff’s trial used a 3-month primary endpoint because the effects of high-load training take time to appear.[8]

Plantar Fasciitis Prevention: What We Know and What We Don’t

In the search for this article, no randomized trial was identified that tested a strategy to prevent plantar fasciitis as its primary outcome. What exists is indirect.

Foot strengthening. In a single-blind randomized trial of 118 recreational long-distance runners, an 8-week foot-core strengthening program followed by remotely supervised training reduced running-related injuries over 12 months. Control participants were 2.42 times more likely to experience a running-related injury (95% CI 1.98–3.62; P = .035).[10] The outcome was any running-related injury, not this condition specifically, so this is encouraging rather than confirmatory.

Orthoses. In a randomized trial of 306 naval recruits over 11 weeks of training, contoured prefabricated foot orthoses were compared with flat insoles. The combined incidence of medial tibial stress syndrome, patellofemoral pain, Achilles tendinopathy, and plantar fasciitis/plantar heel pain was 17.6% with orthoses versus 26.1% with flat insoles (incidence rate ratio 0.66; 95% CI 0.39–1.11; p = 0.098), which was not statistically significant. Adverse events were reported by 20.3% versus 12.4% (relative risk 1.63; 95% CI 0.96–2.76; p = 0.068).[19]

Modifiable risk factors. The authors of the risk-factor meta-analysis concluded that interventions addressing plantarflexion range of motion, body mass index, and body mass, and their load on the force-absorbing plantar surface structures, may be a good starting point for prevention and treatment in active people.[4] The guideline ties onset to changes in weight-bearing activity,[1] so building volume and impact gradually is a logical step. No trial identified in this review has tested that approach for this condition, so treat it as reasoning, not proven prevention.

One mistake I still see in clinical practice is treating plantar fasciitis with rest alone. Reducing an aggravating load can certainly be part of management, but in my experience simply telling a patient to stop and wait is often not enough to move the problem forward.

I usually prefer to give the patient an active plan, with stretching commonly forming part of it, and I often involve a physiotherapist as well. That gives the patient more time to go through the exercises properly, check technique, and adjust the programme to the individual situation. For me, the key difference is between temporarily reducing an aggravating load and leaving the patient without a rehabilitation strategy.

Conclusion: Plantar Fasciitis in Athletes

Plantar fasciitis is common, frustrating, and often slower to settle than patients expect. In my clinical work, I find it most useful to approach it as a primarily clinical diagnosis and to look at the whole loading picture rather than searching for a single mechanical explanation. The exact location of the pain, the first-step pattern, occupational or training load, footwear, and the broader examination all matter more than any one isolated finding.

The treatment evidence is less straightforward than the name of the condition might suggest. Plantar fascia-specific stretching remains well supported, while recent trials have not shown a clear additional benefit from structured strengthening on top of basic care. I therefore would not treat plantar fasciitis as if it were simply another tendinopathy with the same rehabilitation rules. The plantar fascia is a different structure, and the response to loading may be different as well.

In practice, I prefer an active management plan over rest alone. That may include load modification, stretching, selected use of a night splint or taping, and physiotherapy when more guidance is helpful. Corticosteroid injection can sometimes provide short-term relief, but I view it as a temporary option rather than a long-term solution, particularly because of the reported risk of plantar fascia rupture.

The main message for athletes is that recovery usually requires patience and sensible load management rather than complete inactivity. The evidence specific to competitive athletes is still limited, so some decisions inevitably rely on careful clinical judgment. Getting the diagnosis right, avoiding unnecessary overinterpretation of imaging or biomechanics, and giving the tissue enough time to recover are still the most important parts of the process.

Bibliography

[1] https://doi.org/10.2519/jospt.2023.0303

[2] https://doi.org/10.1136/bjsm.36.2.95

[3] https://doi.org/10.1177/23259671221136496

[4] https://doi.org/10.1177/1941738120970976

[5] https://doi.org/10.1136/bjsports-2023-106948

[6] https://doi.org/10.1136/bjsports-2024-108139

[7] https://doi.org/10.1016/j.msksp.2026.103644

[8] https://doi.org/10.1111/sms.12313

[9] https://doi.org/10.1177/2325967118757983

[10] https://doi.org/10.1177/0363546520969205

[11] https://doi.org/10.7547/87507315-93-3-234

[12] https://doi.org/10.5535/arm.2011.35.4.507

[13] https://www.aafp.org/afp/2011/1015/p909

[14] https://doi.org/10.1097/MD.0000000000006621

[15] https://doi.org/10.1136/bjsports-2019-101970

[16] https://doi.org/10.1136/bmj.e3260

[17] https://pubmed.ncbi.nlm.nih.gov/9498581/

[18] https://doi.org/10.1002/jfa2.70067

[19] https://doi.org/10.1136/bjsports-2017-098273